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Design and Evaluation of a Catheter ContactForce Controller for Cardiac Ablation Therapy
Daniel Gelman,* Allan Skanes, Mohammad Ali Tavallaei, and Maria Drangova

Abstract— Goal: Maintaining a constant contact force of an
ablation catheter during cardiac catheter ablation therapy is
clinically challenging due to inherent myocardial motion, often
resulting in poor ablation of arrhythmogenic substrates. To
enable a prescribed contact force to be applied during ablation, a
catheter contact force controller (CCFC) was developed.
Methods: The system includes a hand-held device attached to a
commercial catheter and steerable sheath. A compact linear
motor assembly attaches to an ablation catheter and
autonomously controls its relative position within the shaft of the
steerable sheath. A closed-loop control system is implemented
within embedded electronics to enable real-time catheter-tissue
contact force control. To evaluate the performance of the CCFC,
a linear motion phantom was used to impose a series of
physiological contact force profiles; lesion contact force was
controlled at prescribed levels ranging from 15 to 40 g. Results:
For a prescribed contact force of 25 g, the CCFC was able to
regulate the contact force with a root mean squared error of 3.7 ±
0.7 g. The ability of the CCFC to retract the catheter upon
sudden changes in tissue motion, which may have caused tissue
damage, was also demonstrated. Finally, the device was able to
regulate the contact force for a predetermined amount of time
according to a force-time integral model. Conclusion: The
developed CCFC is capable of regulating catheter-tissue contact
force in a laboratory setting that mimics clinical ablation
therapy. Significance: Catheter-tissue contact force control
promises to improve the precision and success of ablation lesion
delivery.
Index Terms—Catheterization, force control, linear actuators,
real-time systems, medical robotics, robot manipulators.
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I. INTRODUCTION

P

ercutaneous radiofrequency (RF) catheter ablation is
becoming the standard of care for a variety of cardiac
arrhythmias. Cardiac interventionalists introduce ablation
catheters into the heart and manipulate them until the distal tip
contacts the targeted myocardium. Once reached, RF power is
delivered to form ablation lesions that interrupt the electrical
pathways responsible for the arrhythmia. For successful
treatment it is important that these lesions are transmural, as
superficial lesions leave areas of healthy myocardium that
may result in conduction recurrence and ablation failure.
Catheter-tip-to-tissue contact force (CF) has been shown to
be an indicator for assessing lesion development [1-5], and CF
guidelines have been established to label a delivered lesion as
effective [6-8]. Additional studies have shown that monitoring
both the duration of the delivery and CF at a specific RF
power can predict lesion volume [3, 6-11]. Conventionally
described as a Force-Time Integral (FTI), the model may be
used as a prospective quantitative tool to determine lesion
volume under defined parameters. Unfortunately, this model is
dependent on catheter stability and while used in the clinic as
a guide, it has not been used as a quantitative metric that can
predict lesion volume or transmurality. Finally, lesions
delivered with excessive CF present a risk of deep tissue
overheating, which may result in “steam pop”, perforation and

Fig. 1. Modern electromagnetic catheter tracking systems (e.g. CARTO,
Biosense Webster Ltd., Yokneam, Israel) enable visual feedback of the realtime CF experienced on the tip of the catheter (e.g. 7.5F SmartTouch,
Biosense Webster Ltd., Diamond Bar, CA, USA). The figure is a snapshot
demonstrating catheter location in the rendered left atrium (white with green
tip) and the CF as a function of time in the lower right hand corner. Note the
variation in CF with cardiac and respiratory motion. Image courtesy of
London Health Science Center.
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injury outside the heart, including esophageal, pulmonary and
phrenic nerve damage [2]. These potential risks often inhibit
the interventionalist and cause them to deliver the lesion
tentatively, with a lower level of CF to lessen the risk of
injury. Clinically, CF information is often used as a guide to
ensure catheter tip contact and confine the CF within
acceptable ranges, but is ultimately limited by tissue motion,
as seen in the CF profile in the lower right-hand corner of Fig.
1.
While ideally the CF should be regulated within a
prescribed range, interventionalists cannot respond fast
enough to compensate for cardiac and respiratory motion [12].
Approaches to minimize myocardial motion during ablation,
have been proposed, including high-frequency-jet ventilation
[13]. None have successfully provided a motionless
environment in all patients [14]. Kesner et al. [15]
demonstrated CF control of catheters and instruments used for
mitral valve repair, however, the implementation does not
address problems associated with catheter ablation.
Commercial force-sensing ablation catheters enable the
interventionalist to simultaneously monitor the CF in real-time
while delivering the lesion, as illustrated in Fig. 1. Often these
catheters are used together with steerable sheaths, whose
added level of versatility and stability has increased clinical
success [13, 16, 17]. The interventionalist typically
manipulates the steerable sheath until the catheter is pointing
at the target region, and then advances the catheter forward
through the sheath until the desired level of CF is imparted
onto the tissue.
In this manuscript, we introduce a tool that enables the
delivery of effective RF lesions by autonomously regulating
the CF of a force-sensing ablation catheter based only on the
real-time CF measurements. The Catheter Contact-Force
Controller (CCFC) is a hand-held, modular device that enables
robotic control of the catheter within the sheath, which
otherwise would be done manually by the interventionalist.
The CCFC is an add-on tool compatible with commercially
available, preexisting force-sensing ablation catheters and
sheaths.

Clearwater, USA) traveling along a 12 mm diameter 134 mm
long precision magnetic shaft. Movement of the actuator
directly translates to movement of the catheter through the
sheath. The adapter and actuator are mounted within an
enclosure, which is designed to securely lock onto the sheath
handle, while keeping the catheter concentrically mounted
within the hemostatic seal. A set of hinges and latches enables
easy clamping and removal of the CCFC. Both the adapter and
enclosure were fabricated in polypropylene using additive
manufacturing (Objet3D Pro, Stratasys Ltd., Rehovot, Israel).

Fig. 2 Schematic side-view (a) and photograph top-view (b) of the
electromechanical hand-held CCFC attached to a steerable sheath and forcesensing ablation catheter. Movement of the linear actuator along the fixed
magnetic rod moves the catheter through the hemostatic seal of the sheath
handle.

B. Hybrid Control System
To maintain a prescribed CF between the tip of the catheter
and a moving target we implemented a hybrid control system.
Common closed-loop proportional-integral-derivative (PID)
control algorithms are based on minimizing the error between
the desired and actual inputs, and have been shown to be a
viable solution in robotic catheter control systems [15, 18-20].
The CCFC uses a hybrid PID controller, a slight variation of a
standard PID controller, whose control parameters change
based on the error argument. The control signal u(t) is
calculated as:

II. SYSTEM DESCRIPTION
Incorporation of the CCFC replaces the manual
manipulation of the catheter through the sheath. Rather than
advancing the catheter forward until a sufficient CF level is
reached, the interventionalist would engage the CCFC, which
monitors the CF in real-time and updates the position of the
catheter to maintain the CF experienced at the tip of the
catheter at a desired level, despite motion of the target tissue.
The CCFC system comprises a hand-held, compact,
electromechanical device and an embedded system.
A. Hand-Held Device
The hand-held CCFC device, Fig. 2, is mechanically
clamped to the distal end of the sheath handle (i.e. at the
hemostatic seal and insertion point of the catheter). A catheterlocking adapter rigidly clamps the catheter shaft onto a
precision linear actuator (LM2070-040, MICROMO,
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where the error e(t) is the difference between the desired
and current contact forces, FD and FC(t) respectively. The
control parameters KP, KI and KD generate a different control
signal depending on the error measured in real time. If the
error is larger than a predefined CF threshold, FT, the control
system is in an “aggressive” state indicated by KPA, KIA, KDA.
When the error is lower than FT the control system operates in
a “conservative” state indicated by KPC, KIC, KDC. The CF
threshold was empirically assigned to be 5g – a level that was
observed to retain steady-state accuracy.
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Tuning of the aggressive control parameters was achieved
using the Tyrues-Luyben tuning method, as implemented by
[21]. The conservative control parameters were manually
tuned for a desired steady-state response; in the current
implementation, the conservative control parameters were at
least a factor of 4 smaller than the aggressive ones.

Fig. 3. Block diagram of the embedded system controlling the CCFC.

C. Electronic Hardware Design
The hybrid control system was implemented within an
embedded electronic system, enabling real-time control of the
linear actuator. A microcontroller development platform based
on a Atmel SAM3X8E 84 MHz 32-bit ARM architecture
(Due, Arduino LLC, Ivrea, Italy) generates a pulse-width
modulated (PWM) control signal, based on the measured and
desired contact force, which acts as input to the linear actuator
controller and driver circuitry (MCLM-3003, MICROMO,
Clearwater, USA). This daughter board is programmed with a
native velocity proportional-integral (PI) controller that
controls the speed of the motor based on the input PWM
signal. Tuning of the PI controller was performed using the
manufacturer’s tuning software, before tuning the hybrid PID
system. The update rate of the hybrid PID system was set to
1 kHz, which was the maximum rate of the linear actuator
controller. Figure 3 is a block diagram of the designed
embedded system.
D. Linear Motion Phantom
To evaluate the CCFC’s ability to regulate CF on a moving
target in vitro, a custom built linear motion phantom was
developed (Fig. 4). The motion phantom was built to provide
sinusoidal and physiologic motion profiles. A gear motor with
a Hall effect encoder (37D Gearmotor, Pololu Electronics, Las
Vegas, NV, USA) drives a lead screw mechanism providing
linear motion to a carriage. A second PID control system
within an embedded electronic system controls the motion
stage: the circuit board assembly includes a microcontroller
development platform (Due, Arduino LLC, Ivrea, Italy) and a
DC motor driver daughter board (VNH5019 Driver Shield,

Fig. 4. Linear motion phantom with the catheter and sheath loaded, used to
evaluate the CCFC. The linear motion imposed on the tip of the catheter
simulates myocardial tissue motion.

Pololu Electronics, Las Vegas, NV, USA). A strain gauge
capable of detecting force with 200-milligram resolution
(S100, Strain Measurement Devices, Wallingford, CT, USA),
coupled to a linear amplifier (CSG110, FUTEK Inc., Irvine,
CA, USA), is mounted on the carriage and used to measure the
CF of the tip of the catheter. A piece of silicone (Dragon Skin
30, Smooth-On Inc., Macungie, PA, USA) is positioned
between the strain gauge and the tip of the catheter to mimic
soft tissue compliance. A setscrew fixes the sheath firmly in
place without hindering movement of the catheter housed
within the sheath. Linear calibration, according to Hooke’s
law, was first performed to determine the relationship between
the displacement of the tissue and the force measured by the
strain gauge.
The phantom was programmed to execute arbitrary
sinusoidal and sine-sweep motion profiles and to replicate
physiological motion. Contact force profiles were recorded by
force-sensing ablation catheters during typical ablation
procedures, similar to the profile illustrated in Fig. 1. These
profiles, containing both high-frequency low-amplitude
cardiac and low-frequency high-amplitude respiratory motion,
were programmed into the motion phantom as position
trajectories, using the linear calibration parameters.
The signal from the strain gauge, measured in real time, was
used as the CF feedback signal of the CCFC control system
(Fig. 3) and represent a surrogate of the CF signal that would
be provided by a commercial force-sensing catheter.
III. SYSTEM EVALUATION
A. Linear Motion Phantom Evaluation
The linear motion phantom was first evaluated to ensure
that the executed motion profiles mimic the physiological
motion that results in contact force profiles similar to those
measured clinically. The catheter was held fixed while the
linear motion phantom imposed 16 different patient-specific
motion profiles. The sheath was locked in place for half of the
experiments. The real-time CF measurements provided by the
strain gauge were recorded and compared to the corresponding
CF profiles. No attempt was made to perfectly match the
executed CF profiles to the corresponding patient profiles and
the measured CF profiles were only inspected visually,
ensuring the range of amplitudes and frequencies were within
the physiologic range.
B. Catheter Contact-Force Controller Evaluation
Experiments were performed to evaluate the overall
accuracy and dynamic performance of the CCFC. For these
experiments, the CCFC was attached to the rear end of a
commonly used steerable sheath (8F Agilis NxT, St. Jude
Medical, Saint Paul, MN, USA) and CF sensing ablation
catheter (7.5F SmartTouch, Biosense Webster Ltd., Diamond
Bar, CA, USA) combination. Water was introduced via the
sheath’s side port to mimic the clinical setting and reduce the
friction between the sheath and catheter. The sheath and
catheter were inserted into the linear motion phantom as
illustrated in Fig. 5.
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at a desired CF while the linear motion phantom imposed a
patient motion profile. For each FTI/CF combination an
expected duration can be calculated. The CCFC was
programmed to calculate the FTI, and automatically retract the
tip of the catheter back into the sheath once the desired FTI
was reached. The generated CF profile and duration of
catheter engagement was recorded and compared with
expected values. This experiment was then repeated for
various configurations of FTI and CF, which may be userdefined in a clinical setting. The tested FTI values were 500,
1000, and 1500 gs, where each was repeated with 25 and 40 g
of CF. Each configuration was repeated 3 times.
Fig. 5. Experimental setup to used to evaluate the performance of the CCFC.
(a) line drawing (not to scale) showing the CCFC, sheath and catheter
mounted with the linear motion phantom (b); photographs of the CCFC (c)
and motion phantom (d) are also shown.

1) Step Response: The response of the CCFC control
system to a step input (of 25 g) was first evaluated. The step
response was then measured during 25 repeats and the rise
time, overshoot, and peak level were characterized. During
these experiments, the linear motion phantom was kept fixed.
2) Safety: It is important to ensure that the CCFC can
respond to excessive, fast and sudden motions that may result
in tissue perforation. The linear motion phantom was
programmed to impose a bidirectional continuous sine sweep
motion profile, sweeping from 0.1 Hz to 2.5 Hz with
amplitude of 70 g peak-to-peak. This unlikely clinical scenario
was selected following Fourier analysis of over 40 patientspecific CF profiles and determining that the maximum
frequency component observed was 2.5 Hz. While the
phantom executed the prescribed motion, the CCFC was
engaged and attempted to regulate the CF to a desired
reference of 25 g. The maximum error between the desired
and actual contact force was measured. This experiment was
repeated 10 times.
3) Patient-Specific Dynamic Response: To evaluate the
overall performance of the CCFC versus manual intervention,
the linear motion phantom was programed to execute 16
different patient motion profiles. Prior to any evaluation of the
CCFC, a control experiment was performed whereby the
phantom replicated each profile with the CCFC’s disabled.
This is representative of manual intervention, where the
interventionalist contacts the catheter to moving myocardial
tissue and holds the catheter still to deliver a lesion. The
experiment was then repeated with the CCFC programmed to
deliver 15 g, 25 g, and 40 g for the duration of the motion
profile. Statistical analysis of the regulated CF profiles was
performed to calculate mean, confidence interval, and rootmean-squared error (RMSE). Histograms of CF were also
plotted for the “manual” and CCFC interventions. Note that
for this study we use the term “manual” to refer to the CF
profile representative of CF profiles recorded during clinical
ablation procedures.
4) Force-Time Integral: This experiment was designed to
demonstrate that the CCFC could be used not only to regulate
the delivered force, but also to deliver lesions with prescribed
FTI. The CCFC was programmed to deliver a prescribed FTI

IV. RESULTS
A. Linear Motion Phantom
The linear motion phantom was able to replicate a range of
patient-specific CF profiles. The profiles chosen to evaluate
the CCFC are characteristic of typical cardiorespiratory
patterns depicted in Fig. 6(a) as well as irregular profiles
associated with patient motion or catheter instability depicted
in Fig. 6(c). The generated CF curves, shown in Fig. 6(b, d),
visually demonstrate a high level of similarity to the
corresponding clinically acquired profiles (Fig. 6 a and c).
These results demonstrate that the linear motion phantom is
able to replicate cardiorespiratory forces that is typically
encountered during catheter RF delivery and is appropriate to
be used as a phantom for the CCFC’s evaluation. Locking the
sheath in place did not affect the results.

Fig. 6. Two representative patient CF profiles ((a) and (c)) and the
corresponding CF profiles ((b) and (d), respectively) imposed on a fixed
catheter tip by the linear motion phantom, executing the same patient profile.
The motion profiles depicted in (b) and (d) are profile #13 and #3 in Fig. 8(d),
respectively.

B. CCFC – Step Response
The response of the CCFC’s control system to a 25 g step
input is shown in Fig. 7. The following step response
characteristics were calculated from the measurements:
38 ± 3 ms rise time, 3 ± 2 g overshoot, and peak of 29 ± 2 g;
means and standard deviations of 25 repeats of the step
response are reported. The negligible overshoot and oscillation
indicate that the tuning method used to determine the control
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TABLE I
PATIENT MOTION EXPERIMENTS
Prescribed CF (g)
15
25
40
5% Percentile
10.1 ± 1.2
19.7 ± 1.2
34.3 ± 1.2
95% Percentile
20.6 ± 1.3
31.1 ± 1.5
46.9 ± 1.7
Mean
15.3 ± 0.1
25.4 ± 0.1
40.4 ± 0.1
RMSE
3.2 ± 0.6
3.4 ± 0.7
3.9 ± 0.8
All measurements are presented in grams (g) of force. Mean and standard
deviation of all 16 profiles are reported.

Fig. 7. Step response of the CCFC for a reference value of 25 g. At every time
point, the mean and standard deviation are plotted.

parameters has resulted in a desired transient and steady state
response.
C. CCFC – Safety
During the control of a 70 g peak-to-peak sine sweep from
0.1 Hz to 2.5 Hz, the maximum difference between the
prescribed and measured CF was 15 ± 2 g, with all measured
CF values being below 42 g. These results demonstrate that
the CCFC is capable of reacting to sudden changes of tissue
displacement that would otherwise result in large spikes of CF
and potentially cause tissue damage.
D. CCFC – Patient-Specific Dynamic Response
The CCFC was able to significantly transform the CF
profile on the catheter tip in comparison to manual
intervention (p<0.001). Figure 8(a-c) depicts the distribution
of measured CF for three motion profiles, representative of
CFs measured during the delivery of different lesions;
histograms are plotted for both manual and CCFC-controlled
interventions, with a prescribed CF level of 25 g. The images
in Fig. 8(d, manual) and Fig. 8(e, CCFC-controlled) are greyscale representations of the CF histograms for all 16 motion
profiles; they clearly demonstrate that when the CCFC is

Fig. 9. (a) original CF profile (green), while the CCFC was disabled. (b)
illustrates the generated CF profile while the CCFC was engaged to deliver 15
g (blue), 25 g (orange) and 40 g (purple). Histogram (c) and grey-scale
representation (d) illustrate the CF distribution between manual and CCFC
intervention at various desired CF levels. The motion profile depicted here is
profile #1 from Fig. 8(d).

engaged the prescribed mean force is achieved for all motion
profiles.
Similar performance was achieved regardless of the
magnitude of the prescribed CF. Illustrated in Fig. 9, are the
results for one representative experiment where the CCFC was
programmed to deliver a CF of three clinically relevant levels
– 15, 25, and 40 g. Consistently similar force distributions,
were achieved regardless of the prescribed CF value. Detailed
performance metrics – averaged over all tested motion profiles
– are shown in Table I for the three prescribed CF levels.
E. CCFC – Force-Time Integral
For all experiments performed to demonstrate that the
CCFC could achieve a target FTI, the CCFC successfully
engaged the catheter with a desired CF until a target FTI was
reached. The results obtained with each configuration of FTI
and CF are presented in Table II. A representative experiment
is illustrated in Fig. 10. The lesion delivery time was within
480 ± 199 ms of the expected duration. This is indicative of a
regulated CF profile throughout the delivery, as excessive CF
would result in short lesion delivery times and low CF levels
would result in the opposite.
TABLE II
FORCE-TIME INTEGRAL EXPERIMENTS

Fig. 8. Histograms (a)-(c) show the distribution of manual and CCFCcontrolled CF for three unique motion profiles (16,15, and 9 from panel (d),
respectively). The manual intervention histograms indicate that: (a) majority
of lesion time was spent barely touching the tissue, (b) significant myocardial
motion resulting in greatly fluctuation CF, and (c) a precise lesion was
delivered but the force was not centered at the 25 g target. In each case CCFCcontrol brings the mean CF to the target. Histograms of manual (d) and
CCFC-controlled (e) interventions, represented as grey scale values, show a
significant difference in CF distribution for all 16 motion profiles.

Desired
FTI
(gs)
500
1000
1500

CF
(g)
25
40
25
40
25
40

Expected
Duration
(s)
20
12.5
40
25
60
37.5

Measured
FTI
(gs)
500
500
1000
999
1500
1499

CF
(g)
25.7 ± 3.0
40.7 ± 3.5
25.4 ± 3.1
40.4 ± 3.4
25.3 ± 3.0
40.4 ± 3.4

Duration
(s)
19.49 ± 0.01
12.29 ± 0.01
39.36 ± 0.04
24.71 ± 0.01
59.27 ± 0.06
36.99 ± 0.22
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Fig. 10 Interval 0-20 s, the catheter was in contact with the phantom while the
CCFC was disabled. Interval 20-39.5 s, the CCFC was engaged to deliver
500 gs at 25 g. Interval 39.5-45 s, the tip of the catheter retracted into the
sheath once the desired FTI (red) had been reached. The motion profile
depicted here is profile #15 from Fig. 8(d).

With each configuration of desired CF and FTI a similar
profile was generated with an expected and predicable
deviation.
V. DISCUSSION
We have presented a novel and easy to use tool that
regulates the CF imparted by standard ablation catheters on
moving tissue regardless of the type of motion imposed. The
compact hand-held device is used with commercially available
force-sensing ablation catheters and steerable sheaths, which
are widely used in modern electrophysiology suites. The
presented CCFC utilizes the same tools and information
available to the interventionalist but grants the ability to
regulate CF and FTI.
While contact force measurement (at the tip of an ablation
catheter) has been available to electrophysiologists for some
time, it has been used primarily as a visual guide to determine
if adequate contact has been made or if there is a risk of tissue
perforation. The CCFC has been demonstrated to control the
force at the tip of the catheter to within a few grams of a
prescribed force level.
The CF profiles, recorded during clinical ablation
procedures, used to impart clinically relevant motion for
evaluating the CCFC and shown in Fig. 8 demonstrate some of
the problems associated with ablation delivery. For example,
profile #16 (Fig. 8(a)) represents a lesion where negligible
force existed between the catheter tip and the wall during most
of the time RF power was being delivered; when the CCFC
was engaged the mean CF was increased to 25 g, as
prescribed. Similarly, the scenario depicted in Fig. 8(b)
demonstrates large variations in contact force (manual) due to
motion, which is corrected via the use of the CCFC, reducing
the RMSE (about 25 g) from 15.1 to 5.5 g. Even when a tight
distribution of forces is achieved manually, as in Fig. 8(c), the
mean CF may not be at a level sufficiently high for the
delivery of a transmural lesion – use of the CCFC in this case
shifts the distribution of CF from being centered about 15 g to
being centered about 25 g. Consistently narrow, and
symmetric, distributions of CF were also achieved for
different prescribed CF levels (Fig. 9, Table I).
Successful control of CF over the duration of lesion

“delivery” also enabled control of FTI. Automatic engagement
and retraction of the catheter for specified FTI at a desired CF
has the potential to become a fundamental and powerful tool
in the electrophysiology suite. While FTI has been proposed
as a useful measure in predicting lesion transmurality and
volume, without a device like the CCFC FTI cannot be easily
used as a metric clinically or in preclinical studies aimed at
optimizing lesion delivery parameters.
The study evaluating the performance of the CCFC under
conditions of rapidly varying motion have also demonstrated
that use of the CCFC clinically has potential to minimize
tissue damage due to excessive force. The CCFC was able to
compensate for changes in CF as fast as 700 g/s and maintain
CF within 15 g of the prescribed values. These results are
significant because they indicate that using the CCFC, forces
able to perforate tissue [22] would never be achieved.
The CCFC was designed as a hand-held device that would
enable the interventionalist to engage it at any point during a
complete ablation procedure, but is free to perform all other
tasks as is done under current clinical practice. The CCFC can
easily be removed from the catheter/sheath assembly to ensure
optimal catheter steerability and be re-clamped when a target
location has been reached, just prior to RF power delivery.
The device is versatile and can be used as a stand-alone CF
control aid or can be incorporated with catheter robotic
navigation systems for further improvements in position and
force control. Ongoing in vitro and in vivo studies aim to
demonstrate the full effectiveness of the CCFC in controlling
lesion volume.
VI. LIMITATIONS
Despite the extremely promising results, it is important to
note that the study is limited by the fact that the motion of an
in vitro dynamic phantom was used as a surrogate for contact
force measured at the catheter tip during CCFC evaluation; the
limitation is manifested in two ways. First, using a strain
gauge positioned behind tissue-simulating silicone to provide
CF measurements introduced damping of the CF that would
have been measured at the tip of the catheter (i.e. at the
interface of the catheter and silicone). Implementation of the
CCFC with a force-sensing catheter would require re-tuning of
the control parameters to account for the different dynamics.
Second, for the phantom based experiments, the acquired CF
data were implemented as linear motion profiles with the
catheter placed perpendicular to the surface of the tissue. This
experimental design assumed that the catheter was oriented
the same way during acquisition of the clinical data. If
clinically, the catheter tip was oriented at an oblique angle,
larger motion profiles would correspond to the measured
forces. It is likely however that the true characteristics of
myocardial tissue motion will contain the same frequency
components as the profiles used in this study, which ultimately
does not affect the implemented control system of the CCFC.
All CF profiles used to evaluate the CCFC were acquired
from patients undergoing pulmonary vein isolation ablation
therapy and may not be representative of the CF profiles
measured during ablation therapies of the left ventricle.
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During left ventricular ablation procedures CF may change
more rapidly due to systolic motion. The safety experiments
performed as part of the present study contained CF
waveforms with high changes of CF, larger than would be
expected in ventricular ablations, and these preliminary tests
provide confidence that the CCFC will be able to control force
even during ventricular ablations.
VII. CONCLUSIONS
This study represents the first demonstration of contact
force control using a versatile hand-held catheter contact force
controller, which can be coupled to any force-sensing ablation
catheter/steerable sheath combination. The demonstrated
control of contact force under varying motion conditions is
promising and suggests that – when implemented in
combination with a force-sensing catheter – the CCFC can
deliver prescribed ablation lesions.
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